The FDA has approved cabenuva, which consists of rilpivirine and cabotegravir, for treating HIV-1 infection in adults. This therapy is the first once-monthly, long-acting injectable to be approved for the treatment of HIV.

The approval is for a 240 mg injection of nivolumab every 2 weeks or 480 mg every 4 weeks in combination with 40 mg once daily of cabozantinib.
 

Health care providers should be more cognizant of psychological complications and sexual dysfunction risks in women with premature ovarian insufficiency and should work with patients to identify options for relief.
 

Pharmacists can remind patients that seeking treatment helps those around them.

Between 5% to 10% of these lesions will develop into squamous cell carcinoma, a potentially invasive type of skin cancer.
 

Low carbohydrate diets also increased weight loss, reduced medication use, and improved body fat concentrations at 6 months.
 

One of the more recent potential risk factors of COVID-19 is vitamin D deficiency, which is an important modulator of innate and acquired immunity.

Frequent nightmares were not associated with heart medications and sleep-disordered breathing, but were linked with depression, anxiety, and insomnia.
 

During a study investigating therapeutics that target how RNA splicing activates antiviral immune pathways in triple-negative breast cancers, researchers observed that endogenous RNA in tumor cells that had been mis-spliced is able to mimic an RNA virus.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy. 

Study finds that recurring glioblastoma tumors with very few mutations respond significantly better to immunotherapies than similar tumors with multiple mutations.
 

The influence of this treatment continued for centuries.